Impotence in medical clinic outpatients
M. F. Slag, J. E. Morley, M. K. Elson, D. L. Trence, C. J. Nelson, A. E. Nelson, W. B. Kinlaw, H. S. Beyer, F. Q. Nuttall and R. B. Shafer
One thousand one hundred eighty men in a medical outpatient clinic were
screened as to the presence of impotence. Four hundred one men (34%) were
impotent, and of those, 188 (47%) chose to be examined for their problem.
After a comprehensive evaluation the following diagnoses were obtained:
medication effect, 25%; psychogenic, 14%; neurological, 7%; urologic, 6%;
primary hypogonadism, 10%; secondary hypogonadism, 9%; diabetes mellitus,
9%; hypothyroidism, 5%; hyperthyroidism, 1%; hyperprolactinemia, 4%;
miscellaneous, 4%; and unknown causes, 7%. The mean age of the impotent
patients was 59.4 years, and the prevalence of alcoholism was 7%.
Luteinizing hormone, follicle-stimulating hormone, testosterone, thyroxine,
triiodothyronine (T3), T3 resin uptake, and prolactin studies were
necessary to diagnose individual cases. We conclude that erectile
dysfunction is a common and often overlooked problem in middle-aged men
followed in a medical clinic.
Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo
Dunbar et al.
Drug Metab. Dispos. 2006;34:1448-1456.
ABSTRACT
| FULL TEXT
The Prevalence of Erectile Dysfunction in the Primary Care Setting: Importance of Risk Factors for Diabetes and Vascular Disease
Grover et al.
Arch Intern Med 2006;166:213-219.
ABSTRACT
| FULL TEXT
Erectile dysfunction: a need for greater awareness
Lau et al.
The Journal of the Royal Society for the Promotion of Health 2004;124:214-216.
ABSTRACT
Vardenafil Treatment for Erectile Dysfunction
Crowe and Streetman
The Annals of Pharmacotherapy 2004;38:77-85.
ABSTRACT
| FULL TEXT
Optimizing Response To Phosphodiesterase Therapy: Impact of Risk-Factor Management
Guay
J Androl 2003;24:S59-S62.
FULL TEXT
The Need for a Men's Health Initiative
Morley
J. Gerontol. A Biol. Sci. Med. Sci. 2003;58:M614-617.
FULL TEXT
Prevalence of Erectile Dysfunction and Active Depression: An Analytic Cross-Sectional Study of General Medical Patients
Kantor et al.
Am J Epidemiol 2002;156:1035-1042.
ABSTRACT
| FULL TEXT
Perspectives on the Relationship of Adrenal Steroids to Rheumatoid Arthritis
MASI et al.
Ann. N. Y. Acad. Sci. 2002;966:1-12.
ABSTRACT
| FULL TEXT
Do lipid-lowering drugs cause erectile dysfunction? A systematic review
Rizvi et al.
Fam Pract 2002;19:95-98.
ABSTRACT
| FULL TEXT
Editorial: Andropause: Is It Time for the Geriatrician to Treat It?
Morley
J. Gerontol. A Biol. Sci. Med. Sci. 2001;56:263M-265.
FULL TEXT
Physician attitudes and behaviour regarding erectile dysfunction in at-risk patients from a rural community
Perttula
Postgrad. Med. J. 1999;75:83-85.
ABSTRACT
| FULL TEXT
{blacktriangledown}Sildenafil for erectile dysfunction
DTB 1998;36:81-84.
ABSTRACT
| FULL TEXT
Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis
Hajjar et al.
J. Clin. Endocrinol. Metab. 1997;82:3793-3796.
ABSTRACT
| FULL TEXT
Discussing Sexual Concerns with Health Care Professionals: Positive Attitudes in Healthy Subjects
Waterhouse
J Holist Nurs 1993;11:125-134.
ABSTRACT
